SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021550
Filing Date
2022-11-03
Accepted
2022-11-03 07:31:22
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrus-20220930.htm   iXBRL 10-Q 3443922
2 EX-31.1 mrus-ex31_1.htm EX-31.1 21596
3 EX-32.1 mrus-ex32_1.htm EX-32.1 13333
  Complete submission text file 0000950170-22-021550.txt   10471381

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrus-20220930_cal.xml EX-101.CAL 48362
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrus-20220930.xsd EX-101.SCH 42345
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrus-20220930_pre.xml EX-101.PRE 252079
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrus-20220930_def.xml EX-101.DEF 161218
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrus-20220930_lab.xml EX-101.LAB 347448
49 EXTRACTED XBRL INSTANCE DOCUMENT mrus-20220930_htm.xml XML 2291863
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37773 | Film No.: 221356235
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences